Home > Healthcare & Medical Devices > Veterinary Antimicrobial Susceptibility Testing Market
Veterinary Antimicrobial Susceptibility Testing Market size was expected to be valued at USD 100 million in 2022, growing at a CAGR of 5-7% from 2023 to 2032. Antimicrobial Susceptibility Testing (AST) refers to in vitro techniques for determining a bacterium's sensitivity to an antimicrobial agent. The market is set to witness growth owing to the rising threats of antimicrobial resistance, growing demand for animal-derived products, pet insurance, healthcare spending, and increasing government initiatives to tackle antimicrobial resistance.
The increasing livestock population is likely to drive veterinary antimicrobial susceptibility testing market landscape due to the rising development for healthy & good-quality livestock products, which will increase the progression for Antimicrobial Susceptibility Testing (AST). Well-established awareness campaigns for animal disease & treatment, the use of antimicrobial testing, positive government efforts, technological advancements, and the increasing number of research collaborations are some of the drivers that will fuel market expansion.
Based on the product, the automated AST instruments segment will see expansive gains by 2032. The progress can be attributed to the benefits offered by AST instruments. They reduce turnaround & identification time, boosting growth. With innovative computer software, the equipment interprets susceptibility patterns for each organism and produces error-free findings.
Based on the animal type, the livestock segment is poised to hold the largest share by 2032 due to the increasing investments in reducing livestock diseases. For instance, in December 2021, The Asian Development Bank (ADB) signed an agreement to invest up to USD 10 million in Zenex Animal Health India Private Limited (Zenex) to expand the manufacturing & distribution of animal healthcare products and strengthen farmer incomes by decreasing livestock disease risks.
The veterinary antimicrobial susceptibility testing market in North America is expected to witness surging demand due to the rising incidences of antibiotic-resistant infections, increased use of antibiotics, and the presence of major industry players in the region.
The prominent players in the veterinary antimicrobial susceptibility testing industry are BioMérieux SA, Thermo Fisher Scientific, Bruker Corporation, Danaher Corporation, Becton, Dickinson & Company, Synbiosis, Liofilchem S.r.l., HiMedia Laboratories, Bio-Rad Laboratories, Neogen Corporation, Mast Group Ltd., Condalab, FASTinov, Hardy Diagnostics, Bioguard Corporation, and SSI Diagnostica A/S.